Medico Remedies Limited (NSE:MEDICO)

Market Cap	3.82B -38.3%
Revenue (ttm)	1.91B +26.4%
Net Income	115.99M +31.0%
EPS	1.40 +32.1%
Shares Out	n/a
PE Ratio	32.93
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,548
Average Volume	300,648
Open	45.50
Previous Close	46.13
Day's Range	45.50 - 46.20
52-Week Range	37.18 - 67.45
Beta	0.17
RSI	41.55
Earnings Date	Feb 12, 2026

About Medico Remedies

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 213
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MEDICO

Financial Performance

In fiscal year 2025, Medico Remedies's revenue was 1.51 billion, an increase of 4.15% compared to the previous year's 1.45 billion. Earnings were 100.93 million, an increase of 21.74%.